{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T09:58:35Z","timestamp":1790416715515,"version":"4.1.0"},"reference-count":55,"publisher":"Wiley","license":[{"start":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T00:00:00Z","timestamp":1790380800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T00:00:00Z","timestamp":1790380800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Transfusion"],"DOI":"10.1111\/trf.70402","type":"journal-article","created":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T09:11:13Z","timestamp":1790413873000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["From components to pharmaceuticals: A desirable evolution toward precision transfusion medicine"],"prefix":"10.1111","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8042-1494","authenticated-orcid":false,"given":"Melissa M.","family":"Cushing","sequence":"first","affiliation":[{"name":"Department of Pathology and Laboratory Medicine Weill Cornell Medicine  New York New York USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8528-4561","authenticated-orcid":false,"given":"Steven L.","family":"Spitalnik","sequence":"additional","affiliation":[{"name":"Department of Pathology and Cell Biology Columbia University  New York New York USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,9,26]]},"reference":[{"key":"e_1_2_12_2_1","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.cell.2021.01.015","article-title":"Precision medicine in 2030\u2010seven ways to transform healthcare","volume":"184","author":"Denny JC","year":"2021","journal-title":"Cell"},{"key":"e_1_2_12_3_1","unstructured":"Administration UFaD.Guidance for Industry: Q8(R2) Pharmaceutical Development.2009."},{"key":"e_1_2_12_4_1","unstructured":"Administration UFaD.Guidance for Industry: Q10 Pharmaceutical Quality System.2009."},{"issue":"1","key":"e_1_2_12_5_1","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/dom.14587","article-title":"Insulin centennial: milestones influencing the development of insulin preparations since 1922","volume":"24","author":"Owens DR","year":"2022","journal-title":"Diabetes Obes Metab"},{"key":"e_1_2_12_6_1","unstructured":"World Health Organization.WHO global patient blood management guidelines.2021."},{"key":"e_1_2_12_7_1","doi-asserted-by":"crossref","first-page":"4439","DOI":"10.1182\/bloodadvances.2025019005","article-title":"Red blood cell transfusion survival in sickle cell disease is reduced by donor characteristics and recipient spleen activity","volume":"10","author":"Yee MEM","year":"2026","journal-title":"Blood Adv"},{"key":"e_1_2_12_8_1","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1182\/blood-2014-11-567750","article-title":"Established and theoretical factors to consider in assessing the red cell storage lesion","volume":"125","author":"Zimring JC","year":"2015","journal-title":"Blood"},{"key":"e_1_2_12_9_1","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/ejh.70196","article-title":"A clinical prediction model for inadequate hemoglobin response after red blood cell transfusion","volume":"117","author":"Kesharwani R","year":"2026","journal-title":"Eur J Haematol"},{"key":"e_1_2_12_10_1","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1182\/blood.2019000773","article-title":"Effect of donor, component, and recipient characteristics on hemoglobin increments following red blood cell transfusion","volume":"134","author":"Roubinian NH","year":"2019","journal-title":"Blood"},{"key":"e_1_2_12_11_1","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/vox.12068","article-title":"Glucose\u20106\u2010phosphate dehydrogenase deficiency in transfusion medicine: the unknown risks","volume":"105","author":"Francis RO","year":"2013","journal-title":"Vox Sang"},{"key":"e_1_2_12_12_1","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.152598","article-title":"Donor genetic and nongenetic factors affecting red blood cell transfusion effectiveness","volume":"7","author":"Roubinian NH","year":"2022","journal-title":"JCI Insight"},{"key":"e_1_2_12_13_1","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1111\/trf.15833","article-title":"Additive effects of blood donor smoking and gamma irradiation on outcome measures of red blood cell transfusion","volume":"60","author":"DeSimone RA","year":"2020","journal-title":"Transfusion"},{"key":"e_1_2_12_14_1","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1111\/trf.13582","article-title":"Donor variation effect on red blood cell storage lesion: a multivariable, yet consistent, story","volume":"56","author":"Tzounakas VL","year":"2016","journal-title":"Transfusion"},{"key":"e_1_2_12_15_1","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1182\/blood.2019002592","article-title":"A rose is a rose is a rose, or not","volume":"134","author":"Spitalnik SL","year":"2019","journal-title":"Blood"},{"key":"e_1_2_12_16_1","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.146175","article-title":"Blood donor exposome and impact of common drugs on red blood cell metabolism","volume":"6","author":"Nemkov T","year":"2021","journal-title":"JCI Insight"},{"key":"e_1_2_12_17_1","doi-asserted-by":"crossref","first-page":"4284","DOI":"10.1182\/blood-2009-10-245001","article-title":"Transfusion of red blood cells after prolonged storage produces harmful effects that are mediated by iron and inflammation","volume":"115","author":"Hod EA","year":"2010","journal-title":"Blood"},{"key":"e_1_2_12_18_1","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.tmrv.2017.07.006","article-title":"Exploring donor and product factors and their impact on red cell post\u2010transfusion outcomes","volume":"32","author":"Ning S","year":"2018","journal-title":"Transfus Med Rev"},{"key":"e_1_2_12_19_1","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1213\/ANE.0000000000003957","article-title":"Blood substitutes and oxygen therapeutics: a review","volume":"132","author":"Jahr JS","year":"2021","journal-title":"Anesth Analg"},{"key":"e_1_2_12_20_1","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/MOH.0000000000000810","article-title":"Generation of red blood cells from induced pluripotent stem cells","volume":"31","author":"Gunawardena N","year":"2024","journal-title":"Curr Opin Hematol"},{"key":"e_1_2_12_21_1","doi-asserted-by":"crossref","DOI":"10.1186\/s13287-024-03754-9","article-title":"Progresses in overcoming the limitations of in vitro erythropoiesis using human induced pluripotent stem cells","volume":"15","author":"Ju H","year":"2024","journal-title":"Stem Cell Res Ther"},{"key":"e_1_2_12_22_1","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1097\/TA.0000000000002250","article-title":"Artificial oxygen carriers and red blood cell substitutes: a historic overview and recent developments toward military and clinical relevance","volume":"87","author":"Bialas C","year":"2019","journal-title":"J Trauma Acute Care Surg"},{"key":"e_1_2_12_23_1","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1046\/j.1423-0410.1999.7610043.x","article-title":"Economic impact of donor platelet count and platelet yield in apheresis products: relevance for emerging issues in platelet transfusion therapy","volume":"76","author":"Goodnough LT","year":"1999","journal-title":"Vox Sang"},{"key":"e_1_2_12_24_1","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.tmrv.2018.04.001","article-title":"Platelet storage lesions: what more do we know now?","volume":"32","author":"Ng MSY","year":"2018","journal-title":"Transfus Med Rev"},{"key":"e_1_2_12_25_1","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1111\/trf.70305","article-title":"Assessment of the efficacy of large volume delayed sampling primary culture and pathogen reduction in preventing septic reactions from platelet transfusions","volume":"66","author":"Jacobs MR","year":"2026","journal-title":"Transfusion"},{"key":"e_1_2_12_26_1","doi-asserted-by":"crossref","first-page":"eadi4490","DOI":"10.1126\/scitranslmed.adi4490","article-title":"Ultrasoft platelet\u2010like particles stop bleeding in rodent and porcine models of trauma","volume":"16","author":"Nellenbach K","year":"2024","journal-title":"Sci Transl Med"},{"key":"e_1_2_12_27_1","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abb8975","article-title":"Platelet\u2010mimicking procoagulant nanoparticles augment hemostasis in animal models of bleeding","volume":"14","author":"Sekhon UDS","year":"2022","journal-title":"Sci Transl Med"},{"key":"e_1_2_12_28_1","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-21384-z","article-title":"Intravenous synthetic platelet (SynthoPlate) nanoconstructs reduce bleeding and improve \u2018golden hour\u2019 survival in a porcine model of traumatic arterial hemorrhage","volume":"8","author":"Hickman DA","year":"2018","journal-title":"Sci Rep"},{"key":"e_1_2_12_29_1","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1182\/blood.2025031826","article-title":"A dried platelet\u2010derived biologic for blood\u2010brain barrier repair and hemorrhage control after TBI in mice","volume":"147","author":"Trivedi A","year":"2026","journal-title":"Blood"},{"key":"e_1_2_12_30_1","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1365-2141.2004.04973.x","article-title":"Is fresh frozen plasma clinically effective? A systematic review of randomized controlled trials","volume":"126","author":"Stanworth SJ","year":"2004","journal-title":"Br J Haematol"},{"key":"e_1_2_12_31_1","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1007\/s11239-018-1789-9","article-title":"Individual differences of plasma proteins and factors in fresh frozen plasma from Chinese regional blood donors","volume":"47","author":"Zhu L","year":"2019","journal-title":"J Thromb Thrombolysis"},{"key":"e_1_2_12_32_1","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1423-0410.2011.01518.x","article-title":"Fresh frozen plasma quality: relation to age and gender of blood donors","volume":"102","author":"Madla W","year":"2012","journal-title":"Vox Sang"},{"key":"e_1_2_12_33_1","article-title":"Prophylactic plasma transfusion for patients without inherited bleeding disorders or anticoagulant use undergoing non\u2010cardiac surgery or invasive procedures","volume":"11","author":"Huber J","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_12_34_1","article-title":"Superiority of fibrinogen concentrate versus cryoprecipitate for treatment of bleeding in cardiac surgery patients: a secondary analysis of the FIBRES randomized clinical trial stratified by surgical risk","author":"Bartoszko J","year":"2026","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"e_1_2_12_35_1","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1001\/jama.2025.3501","article-title":"Prothrombin complex concentrate vs frozen plasma for Coagulopathic bleeding in cardiac surgery: the FARES\u2010II multicenter randomized clinical trial","volume":"333","author":"Karkouti K","year":"2025","journal-title":"JAMA"},{"key":"e_1_2_12_36_1","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1056\/NEJMra2506021","article-title":"Antidotes for anticoagulation reversal","volume":"394","author":"Rocca B","year":"2026","journal-title":"N Engl J Med"},{"key":"e_1_2_12_37_1","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13017-024-00554-7","article-title":"Strategies to prevent blood loss and reduce transfusion in emergency general surgery, WSES\u2010AAST consensus paper","volume":"19","author":"Coccolini F","year":"2024","journal-title":"World J Emerg Surg"},{"key":"e_1_2_12_38_1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1213\/ANE.0000000000005513","article-title":"Pro\u2010con debate: fibrinogen concentrate or cryoprecipitate for treatment of acquired hypofibrinogenemia in cardiac surgical patients","volume":"133","author":"Hensley NB","year":"2021","journal-title":"Anesth Analg"},{"key":"e_1_2_12_39_1","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11010001","article-title":"Management of coagulopathy in bleeding patients","volume":"11","author":"Hofer S","year":"2021","journal-title":"J Clin Med"},{"key":"e_1_2_12_40_1","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1213\/ANE.0000000000004478","article-title":"Pathophysiological response to trauma\u2010induced coagulopathy: a comprehensive review","volume":"130","author":"Duque P","year":"2020","journal-title":"Anesth Analg"},{"issue":"1","key":"e_1_2_12_41_1","first-page":"S16","article-title":"Postpartum hemorrhage: when uterotonics and sutures fail","volume":"87","author":"James AH","year":"2012","journal-title":"Am J Hematol"},{"key":"e_1_2_12_42_1","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1055\/s-0034-1398383","article-title":"Hemostatic and thrombotic issues in cardiac surgery","volume":"41","author":"Ranucci M","year":"2015","journal-title":"Semin Thromb Hemost"},{"key":"e_1_2_12_43_1","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1007\/s11239-022-02695-5","article-title":"Thromboembolism after treatment with 4\u2010factor prothrombin complex concentrate or plasma for warfarin\u2010related bleeding","volume":"54","author":"Go AS","year":"2022","journal-title":"J Thromb Thrombolysis"},{"key":"e_1_2_12_44_1","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.14629","article-title":"What is the optimal management of thromboprophylaxis after liver transplantation regarding prevention of bleeding, hepatic artery, or portal vein thrombosis? A systematic review of the literature and expert panel recommendations","volume":"36","author":"Kirchner VA","year":"2022","journal-title":"Clin Transplant"},{"key":"e_1_2_12_45_1","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/ejh.13610","article-title":"Recombinant factor VIII fc for the treatment of haemophilia a","volume":"106","author":"Hermans C","year":"2021","journal-title":"Eur J Haematol"},{"key":"e_1_2_12_46_1","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1055\/s-0040-1718887","article-title":"Enhanced half\u2010life recombinant factor VIII concentrates for hemophilia a: insights from pivotal and extension studies","volume":"47","author":"Minno MND","year":"2021","journal-title":"Semin Thromb Hemost"},{"key":"e_1_2_12_47_1","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1056\/NEJMoa2517384","article-title":"Mim8 bispecific antibody prophylaxis in hemophilia a with or without inhibitors","volume":"394","author":"Mancuso ME","year":"2026","journal-title":"N Engl J Med"},{"key":"e_1_2_12_48_1","doi-asserted-by":"crossref","first-page":"3409","DOI":"10.1182\/bloodadvances.2025019054","article-title":"A revised classification of FVIII concentrates: rationale and novel metrics","volume":"10","author":"Hermans C","year":"2026","journal-title":"Blood Adv"},{"key":"e_1_2_12_49_1","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1537-2995.2011.03247.x","article-title":"Transfusion\u2010associated circulatory overload after plasma transfusion","volume":"52","author":"Narick C","year":"2012","journal-title":"Transfusion"},{"key":"e_1_2_12_50_1","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1182\/blood-2011-08-370932","article-title":"Transfusion\u2010related acute lung injury: incidence and risk factors","volume":"119","author":"Toy P","year":"2012","journal-title":"Blood"},{"issue":"1","key":"e_1_2_12_51_1","first-page":"65s","article-title":"Adverse effects of plasma transfusion","volume":"52","author":"Pandey S","year":"2012","journal-title":"Transfusion"},{"key":"e_1_2_12_52_1","doi-asserted-by":"crossref","DOI":"10.3390\/app16052302","article-title":"Are polymeric microparticles dangerous for red blood cells?","volume":"16","author":"Gural A","year":"2026","journal-title":"Appl Sci"},{"key":"e_1_2_12_53_1","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1182\/bloodadvances.2025018716","article-title":"Sickle cell visualization in vivo in humans: microvascular occlusion formation and hemorheological indices","volume":"10","author":"Morakis MM","year":"2026","journal-title":"Blood Adv"},{"key":"e_1_2_12_54_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.brci.2026.100054","article-title":"Defining and quantifying oxygen delivery potency of blood products","volume":"2","author":"Rogers SC","year":"2026","journal-title":"Blood Red Cells Iron"},{"key":"e_1_2_12_55_1","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1111\/trf.70241","article-title":"Cord blood red cell concentrates for preterm neonate transfusion: insights from the multicenter BORN trial","volume":"66","author":"Pellegrino C","year":"2026","journal-title":"Transfusion"},{"key":"e_1_2_12_56_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2025.103426","article-title":"Cord red blood cell transfusions for severe retinopathy in preterm neonates in Italy: a multicenter randomized controlled trial","volume":"87","author":"Teofili L","year":"2025","journal-title":"EClinicalMedicine"}],"container-title":["Transfusion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/trf.70402","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/trf.70402","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/trf.70402","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T09:11:20Z","timestamp":1790413880000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/trf.70402"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,26]]},"references-count":55,"alternative-id":["10.1111\/trf.70402"],"URL":"https:\/\/doi.org\/10.1111\/trf.70402","archive":["Portico"],"relation":{},"ISSN":["0041-1132","1537-2995"],"issn-type":[{"value":"0041-1132","type":"print"},{"value":"1537-2995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,26]]},"assertion":[{"value":"2026-08-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-15","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-26","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"trf.70402"}}